APA (7th ed.) Citation

Poh, X. Y., Lee, I. R., Lim, C., Teo, J., Rao, S., Chia, P. Y., . . . Young, B. E. (2022). Evaluation of the safety and immunogenicity of different COVID-19 vaccine combinations in healthy individuals: Study protocol for a randomized, subject-blinded, controlled phase 3 trial [PRIBIVAC]. Trials, 23(1), 1. https://doi.org/10.1186/s13063-022-06345-2

Chicago Style (17th ed.) Citation

Poh, Xuan Ying, et al. "Evaluation of the Safety and Immunogenicity of Different COVID-19 Vaccine Combinations in Healthy Individuals: Study Protocol for a Randomized, Subject-blinded, Controlled Phase 3 Trial [PRIBIVAC]." Trials 23, no. 1 (2022): 1. https://doi.org/10.1186/s13063-022-06345-2.

MLA (9th ed.) Citation

Poh, Xuan Ying, et al. "Evaluation of the Safety and Immunogenicity of Different COVID-19 Vaccine Combinations in Healthy Individuals: Study Protocol for a Randomized, Subject-blinded, Controlled Phase 3 Trial [PRIBIVAC]." Trials, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s13063-022-06345-2.